Adaptimmune Therapeutics Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Adaptimmune Therapeutics plc - American Depositary Shares (ADAP)
Last adaptimmune therapeutics plc - american depositary shares earnings: 5/9 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.adaptimmune.com/phoenix.zhtml?c=253991&p=irol-newsarticle&id=2255800
Company Research
Source: Yahoo! Finance
All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue exceeded analyst estimates by 100%. Earnings per share (EPS) also surpassed analyst estimates by 87%. Looking ahead, revenue is forecast to grow 4.6% p.a. on average during the next 3 years, compared to a 22% growth forecast for the Biotechs industry in the US. Performance of the American Biotechs industry. The company's shares are down 26% from a week ago. You should always think about risks. Case in point, we've spotted 4 warning signs for Adaptimmune Therapeutics you should be aware of, and 1 of them is a bit unpleasant. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. I
Show less
Read more
Impact Snapshot
Event Time:
ADAP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADAP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADAP alerts
High impacting Adaptimmune Therapeutics plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
ADAP
News
- Adaptimmune Announces Changes to its Executive Leadership Team Based in The UK [Yahoo! Finance]Yahoo! Finance
- First Patient Treated with Adaptimmune's TECELRA(R) (afamitresgene autoleucel) [Yahoo! Finance]Yahoo! Finance
- Adaptimmune Therapeutics plc (NASDAQ: ADAP) had its price target lowered by analysts at Mizuho from $3.00 to $1.50. They now have an "outperform" rating on the stock.MarketBeat
- Dr Crystal Mackall Confirmed to Keynote Immuno-Oncology 360º 2025PR Web
- Yahoo Finance [Yahoo! Finance]Yahoo! Finance
ADAP
Earnings
- 11/13/24 - Beat
ADAP
Sec Filings
- 12/19/24 - Form 8-K
- 12/5/24 - Form SCHEDULE
- 11/13/24 - Form 10-Q
- ADAP's page on the SEC website